Info Day about the EU's Falsified Medicines Directive with OCS Checkweighers
securPharm invites to the 3rd Conference on Falsified Medicines Directive 2011/62/EU on March 16, 2016, in Frankfurt /Main. The legislative process is complete for the delegated act that determines the technical and organizational provisions for implementing the directive, which is designed to protect patients from counterfeit drugs. The Delegated Regulation (EU) 2016/161 was officially published on February 9, 2016.
For the participants in the pharmaceutical supply chain in Germany, the schedule is now clear: The delegated act entered into force as of February 2016. This marks the start of the three-year implementation period for all safety measures. These new safety features will become a mandatory requirement on 2/9/2019. If the products affected do not comply with these provisions, they cannot be distributed to the market. It is high time to act!
Authorities from the EU Commission and the Federal Ministry of Health provided information and answers to the participants in the pharmaceutical supply chain. Experts from securPharm, ACS PharmaProtect, and other drug distributors discussed the current implementation status of authentication systems in Germany and the associated challenges, in particular, for pharmaceutical companies.
OCS Checkweighers is a partner of securPharm and sends its Track & Trace experts to Frankfurt. A live demonstrator shows all stations in the packaging cycle of a pharma product relevant to the falsification directive. This includes generating the print labels and the internal administration of serial numbers, the printing of the packages, the input of data to the securPharm system, and the checking and acceptance at the pharmacy..